Fundraising FoxLime Street Ventures
Venture capitalBoston · Pre-Seed–Seed · 2 people tracked
Find your way into Lime Street Ventures
Sign up to see every warm intro you have to Lime Street Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lime Street Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Early-stage tech and life sciences investor primarily focused on the Boston and Cambridge ecosystem.
Source: firm website, verified Aug 6, 2026.
Team · 2 people
from public directoriesFrequently asked questions
- What stage does Lime Street Ventures invest at?
- Lime Street Ventures invests at the Pre-Seed, Seed stages.
- What sectors does Lime Street Ventures focus on?
- Lime Street Ventures focuses on Biotech, Healthtech, Sector Agnostic.
- Where is Lime Street Ventures located?
- Lime Street Ventures is headquartered in Boston, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Felicis is a venture capital firm that backs early-stage founders, investing primarily at Seed and Series A across artificial intelligence, cybersecurity and defense, global resilience and energy, and health and bio.